ArticleBioscience reports2022

Syrbactin-class dual constitutive- and immuno-proteasome inhibitor TIR-199 impedes myeloma-mediated bone degeneration in vivo.

Vasudha Tandon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.